Heerspink HJL, Kiyosue A, Wheeler DC, Lin M, et al. Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial. Lancet 2023 Nov 2:S0140-6736(23)02230-4. doi: 10.1016/S0140-6736(23)02230.
PMID: 37931629